- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05439109
Correct Endotracheal Tube Placement Using Topographical Landmarks
June 25, 2022 updated by: Dr. Amit Kumar Mittal, Rajiv Gandhi Cancer Institute & Research Center, India
To Evaluate the Appropriate Depth of Endotracheal Tube Placement Guided by Topographical Landmarks
An optimal endotracheal tube depth is ideally required for preventing the complications associated with mal-positioning of the endotracheal tube.
The topographical technique of tube placement considering the individual's morphometric dimensions could help to provide optimal tube placement.
hence, to evaluate the efficacy of the topographical technique in providing the optimal tube placement this study will be conducted.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
The trachea is a dynamic organ and its length varies by various static and dynamic factors leading to changing the tracheal length and variable endotracheal tube tip to carina (Ti-Ca) distance.
Hence, upholding optimal Ti-Ca distance during changing tracheal length is of utmost importance to prevent complications associated with endotracheal tube (ETT) mal-positioning.
When the length of ETT, which is to be inserted inside the trachea, is calculated as per an individual's tracheal morphometric dimensions, the appropriate depth of placement could be achieved and tube malpositioning can be prevented.
In the topographical landmark technique, an individual tracheal length is estimated by measuring the various distance from mid-thyroid level (corresponds to vocal cords) to manubriosternal joint (corresponds to carina) in the sagittal plane.
After estimating the tracheal length, tip to carina distance of 3cm was deducted from the estimated length of the trachea to provide the distance of the endotracheal tube to be kept beyond the vocal cords.
Hence, the investigators planned this study to find the "utility and reliability" of the topographical landmark technique compared to the conventional intubation guide mark technique in providing the appropriate depth of endotracheal tube placement.
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amit K Mittal, M.D
- Phone Number: 09717611416
- Email: amitrgci@gmail.com
Study Contact Backup
- Name: Anil K Patel, DNB
- Phone Number: 09781364051
- Email: anilpatel2811@gmail.com
Study Locations
-
-
Delhi
-
Rohini, Delhi, India, 110085
- Amit
-
Contact:
- Amit Kr Mittal, MD
- Phone Number: 09717611416
- Email: amitrgci@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
• Age group of 18-75 years
- ASA physical status I-III patients
- Oral intubation for general anesthesia
Exclusion Criteria:
• Patient with upper airway fibrosis
- Tracheal stenosis or tracheal surgeries
- Previous head and neck surgeries
- Contracture neck or irradiated neck
- Large neck swelling distorting or deviating the trachea
- Laryngeal or tracheal tumor
- Intubations requiring flexo-metallic tubes
- Patient refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Topographical landmark technique
Surface anatomic landmarks of an individual's trachea will be measured from the mid-thyroid level (corresponds to vocal cords) to manubriosternal joint (corresponds to carina) in the sagittal plane to estimate tracheal length.
Three centimeters will be deducted from the estimated tracheal length to provide the length of the endotracheal tube from the tube tip to be inserted inside the trachea.
|
An endotracheal tube will be placed inside the trachea after measuring the individual's estimated tracheal dimensions.
|
Active Comparator: Intubation guide mark technique
Already established and commonly practiced technique, in this technique, the guide mark present above the proximal end of the endotracheal tube cuff will be placed just beyond the vocal cords.
|
An endotracheal tube will be placed in this group by using the intubation guide mark.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endotracheal tube position inside the trachea
Time Frame: through study completion approximately at six months
|
Tip to carina distance will be measured by fiber optic bronchoscopy to classify the optimal or suboptimal tube placements in both groups
|
through study completion approximately at six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Amit K Mittal, M.D, Senior Consultant, Department of Anesthesiology, Rajiv Gandhi Cancer Institute and Research centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2022
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
January 31, 2023
Study Registration Dates
First Submitted
June 21, 2022
First Submitted That Met QC Criteria
June 25, 2022
First Posted (Actual)
June 30, 2022
Study Record Updates
Last Update Posted (Actual)
June 30, 2022
Last Update Submitted That Met QC Criteria
June 25, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- RES/SCM/35/2019/68
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
If necessary IPD data can be disclosed after patients approval.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anatomic Landmarks
-
Ain Shams UniversityUnknownRadiography | Anatomic Landmarks | Echocardiography, Transesophageal | Catheterization, Central VenousEgypt
-
Derince Training and Research HospitalKocaeli UniversityCompletedPediatrics | Anatomic Abnormality | Anatomy | Anatomic Landmarks | AnthropometryTurkey
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions
-
The Cleveland ClinicCompleted
-
The Cleveland ClinicCompletedAnatomic Total Shoulder ArthroplastyUnited States
-
The Cleveland ClinicCompletedAnatomic Total Shoulder ArthroplastyUnited States
-
M.D. Anderson Cancer CenterCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Aldy HeriwarditoCompletedFemoral Artery and Vein Distance | AnatomicIndonesia
-
Ohio State University Comprehensive Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingA Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast CancerAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
Clinical Trials on Topographical landmark technique of endotracheal tube placement
-
Equipo de Terapia IntravenosaHospital San Carlos, MadridCompleted
-
John LaffeyCompletedPerformance and Safety of an Airway Management DeviceIreland
-
Isfahan University of Medical SciencesCompleted
-
Antalya Training and Research HospitalCompletedComparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated PatientsDisorder of AbdomenTurkey
-
Rajiv Gandhi Cancer Institute & Research Center...UnknownRobotic Surgical ProceduresIndia
-
South Infirmary-Victoria University HospitalCompleted
-
Azienda Ospedaliera Universitaria Integrata VeronaRecruiting
-
University Hospital, MontpellierRecruiting
-
University Health Network, TorontoCompleted
-
Capital Medical UniversityCompletedAcute Brain InjuryChina